TP53 and head and neck squamous cell carcinoma: Whilst this review and meta-analysis further supports the hypothesis that TP53 mutational status is of prognostic value in HNSCC, a well-designed prospective, multi-centre trial is needed to definitively answer this question prior to clinical translation.